IOPtima Launches OT-135

IOPtima is launching its next generation IOPtiMate TM system the "OT-135" at the 2009 AAO conference, currently taking place in San Francisco.

The advanced model of this technology includes operational modifications, ergonomic and other improvements to the system.

The company is currently running a Wet Lab demonstration at the conference where leading glaucoma surgeons worldwide are training the IOPtiMate TM system on cadaver eyes.

The company believes that this demonstration will assist and highlighting the IOPtiMate advantages as compared to alternative treatments available for glaucoma.

IOptima is a subsidiary of Bio-Light, Israeli Life Sciences Investments Ltd., a management and holding company specializing in developing Life Sciences developments. Bio-Light is traded on the Israeli Stock Exchange under the symbol TASE:BOLT.